{"product_id":"uae-veterinary-ointments-creams-plant-complete-feasibility-study-business-plan-p","title":"UAE Veterinary Ointments \u0026 Creams Plant - Complete Feasibility Study \u0026 Business Plan Package","description":"\u003cp\u003e\u003cem\u003eThe costliest disease in dairy farming is treated, across this region, with products almost none of which are made here.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eOverview\u003c\/h2\u003e\n\u003cp\u003eMastitis anchors the demand case in this package, which documents a UAE plant producing veterinary ointments, creams and sterile intramammary infusions. Local manufacture is negligible, so a growing regional market is supplied almost entirely from outside it, and global ranges built for other herds leave regionally specific needs under-served. Food-security policy is expanding the animal base that generates the demand.\u003c\/p\u003e\n\u003cp\u003eThe technical core is two manufacturing processes rather than one: sterile intramammary infusions, with everything sterility implies for the facility, and non-sterile topical ointments and creams. Both are documented. Around them the study sets out market context and demand structure, export markets, competition, capacity, equipment and capital investment, manpower, and the veterinary regulatory framework — one that rewards a manufacturer with local presence over a supplier working at a distance. Cost and service advantages over imports are quantified for investors.\u003c\/p\u003e\n\u003ch2\u003eWhat this system covers\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eSterile intramammary infusion manufacture — the process, its equipment and the conditions it demands\u003c\/li\u003e\n\u003cli\u003eTopical ointment and cream production — the second documented process and what it requires\u003c\/li\u003e\n\u003cli\u003eMastitis-led demand structure — the dairy economics behind the largest single product call\u003c\/li\u003e\n\u003cli\u003eVeterinary regulatory framework — the compliance conditions that favour a local manufacturer\u003c\/li\u003e\n\u003cli\u003eRegional and export markets — demand beyond the UAE, and the gap global ranges leave behind\u003c\/li\u003e\n\u003cli\u003eCapacity, equipment and capital investment — the plant specification and what it costs to build\u003c\/li\u003e\n\u003cli\u003eImport displacement, risk and emirate choice — quantified advantages, named risks, licensing and location\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWho it's for\u003c\/h2\u003e\n\u003cp\u003ePharmaceutical and agri-vet investors, animal-health companies and business developers pursuing veterinary manufacturing in the UAE and GCC. The trigger is typically a distributor deciding whether to make what it currently imports, or an industrial investor screening a regulated pharmaceutical opportunity with a defined demand anchor behind it. What they take away is a dual-process technical case, a regulatory picture and an editable financial model, enough to put the question to a board.\u003c\/p\u003e","brand":"Apex Global Solutions AGS","offers":[{"title":"Default Title","offer_id":56792714051924,"sku":"AGS-06-022","price":1290.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1052\/4996\/4372\/files\/AGS-06-022_Veterinary_Ointment_Cream.png?v=1786639547","url":"https:\/\/agskits.com\/products\/uae-veterinary-ointments-creams-plant-complete-feasibility-study-business-plan-p","provider":"Apex Global Solutions","version":"1.0","type":"link"}